Product Images Lacosamide

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Lacosamide NDC 83090-012 by Sintetica Us Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 3 - lacosamide 014

Figure 3 - lacosamide 014

``` Proportion of Patients Figure 3 - Kaplan-Meier Analysis of Time to 21 PGTC Seizure (Study 5) Analysis Set: Modified Full Analysis Set Statistical data indicates a significant reduction in the occurrence of seizures for patients in the treatment group compared to the placebo group. The analysis shows a 52% reduction in seizure frequency with the medication PR 540. The chart displays a comparative analysis of the time taken for patients to experience 21 PGTC seizures between the two groups.```*

Principal display panel - 20 mL vial carton - lacosamide 015

Principal display panel - 20 mL vial carton - lacosamide 015

Chemical structure - lacosamideinjection 011

Chemical structure - lacosamideinjection 011

Figure 1 - lacosamideinjection 012

Figure 1 - lacosamideinjection 012

Figure 2 - lacosamideinjection 013

Figure 2 - lacosamideinjection 013

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.